表紙
市場調查報告書

心臟瓣膜維修、替換設備的全球市場:2019年∼2023年

Global Heart Valve Repair and Replacement Devices Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 823159
出版日期 內容資訊 英文 127 Pages
訂單完成後即時交付
價格
Back to Top
心臟瓣膜維修、替換設備的全球市場:2019年∼2023年 Global Heart Valve Repair and Replacement Devices Market 2019-2023
出版日期: 2019年03月29日內容資訊: 英文 127 Pages
簡介

由於心血管疾病的罹患率增加,將促進今後數年心臟瓣膜維修、替換設備市場成長。主動脈閥狹窄症,肺動脈瓣狹窄症,由於先天性心臟衰竭等疾病,提高心臟瓣膜的修復替換設備的需求。再加上香煙的濫用,高膽固醇,血壓,肥胖等的要素,也長期性成為對心臟瓣膜的維修、替換設備需求增加的主要原因。Technavio的分析師預測,全球心臟瓣膜維修、替換設備市場至2023年,預計將以約16%的年複合成長率成長。

本報告提供全球心臟瓣膜維修、替換設備市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測(2018年∼2023年)
  • 心臟瓣膜置換設備
  • 心臟瓣膜維修設備
  • 市場機會:各產品

第7章 市場區隔:各手術

  • 市場區隔:各手術
  • 各手術比較:市場規模及預測(2018年∼2023年)
  • 微創手術
  • 經導管手術
  • 開放性手術
  • 市場機會:各手術

第8章 客戶形勢

第9章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 技術的進步
  • 再生醫療方法的心臟瓣膜的開發
  • 產業的發展

第13章 業者情勢

  • 概要
  • 創造性破壞狀況

第14章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott
  • Boston Scientific Corporation
  • CryoLife, Inc
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Medtronic

第15章 附錄

  • 調查方法
  • 簡稱的清單

第16章 關於TECHNAVIO

目錄
Product Code: IRTNTR31074

About this market

The increasing prevalence of cardiovascular diseases will drive the heart valve repair and replacement devices market growth in the forthcoming years. Disorders including the aortic stenosis, pulmonary stenosis, and a congenital heart defect have led to rising demand for heart valve repair and replacement devices. In addition, factors including tobacco abuse, high cholesterol, blood pressure, and obesity are also mainly responsible for creating a rising demand for heart valve repair and replacement devices in the long run. Technavio's analysts have predicted that the heart valve repair and replacement devices market will register a CAGR of nearly 16% by 2023.

Market Overview

Rising demand for heart valve therapies

One of the growth drivers of the global heart valve repair and replacement devices market is the rising demand for heart valve therapies. The growing incidence of heart valve diseases such as stenosis and regurgitation led to the high demand for heart valve therapies such as heart valve repair and replacement.

Shortage of cardiologists

One of the challenges in the growth of the global heart valve repair and replacement devices market is the shortage of cardiologists. Lack of expertise increases the probability of misdiagnosis and improper treatment care, which can cause harm to patients.

For the detailed list of factors that will drive and challenge the growth of the heart valve repair and replacement devices market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Vendors in the market are focusing on strategies such as mergers and acquisitions, partnerships, and other developments to improve their market share and expand their presence globally. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Heart valve replacement devices - Market size and forecast 2018-2023
  • Heart valve repair devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY SURGERY

  • Market segmentation by surgery
  • Comparison by surgery
  • Minimally invasive surgeries - Market size and forecast 2018-2023
  • Transcatheter surgeries - Market size and forecast 2018-2023
  • Open surgeries - Market size and forecast 2018-2023
  • Market opportunity by surgery

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Technological advances
  • Development of heart valve with tissue engineering approach
  • Industry developments

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Boston Scientific Corporation
  • CryoLife, Inc
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Medtronic

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations

PART 16: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global medical devices market
  • Exhibit 02: Segments of global medical devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Heart valve replacement devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Heart valve replacement devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Heart valve repair devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Heart valve repair devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by product
  • Exhibit 24: Surgery - Market share 2018-2023 (%)
  • Exhibit 25: Comparison by surgery
  • Exhibit 26: Minimally invasive surgeries - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 27: Minimally invasive surgeries - Year-over-year growth 2019-2023 (%)
  • Exhibit 28: Transcatheter surgeries - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: Transcatheter surgeries - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Open surgeries - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Open surgeries - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Market opportunity by surgery
  • Exhibit 33: Customer landscape
  • Exhibit 34: Market share by geography 2018-2023 (%)
  • Exhibit 35: Geographic comparison
  • Exhibit 36: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 39: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 41: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 42: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 43: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 44: Key leading countries
  • Exhibit 45: Market opportunity
  • Exhibit 46: Impact of drivers and challenges
  • Exhibit 47: Vendor landscape
  • Exhibit 48: Landscape disruption
  • Exhibit 49: Vendors covered
  • Exhibit 50: Vendor classification
  • Exhibit 51: Market positioning of vendors
  • Exhibit 52: Abbott - Vendor overview
  • Exhibit 53: Abbott - Business segments
  • Exhibit 54: Abbott - Organizational developments
  • Exhibit 55: Abbott - Geographic focus
  • Exhibit 56: Abbott - Segment focus
  • Exhibit 57: Abbott - Key offerings
  • Exhibit 58: Boston Scientific Corporation - Vendor overview
  • Exhibit 59: Boston Scientific Corporation - Business segments
  • Exhibit 60: Boston Scientific Corporation - Organizational developments
  • Exhibit 61: Boston Scientific Corporation - Geographic focus
  • Exhibit 62: Boston Scientific Corporation - Segment focus
  • Exhibit 63: Boston Scientific Corporation - Key offerings
  • Exhibit 64: CryoLife, Inc - Vendor overview
  • Exhibit 65: CryoLife, Inc - Business segments
  • Exhibit 66: CryoLife, Inc - Organizational developments
  • Exhibit 67: CryoLife, Inc - Geographic focus
  • Exhibit 68: CryoLife, Inc - Segment focus
  • Exhibit 69: CryoLife, Inc - Key offerings
  • Exhibit 70: Edwards Lifesciences Corporation - Vendor overview
  • Exhibit 71: Edwards Lifesciences Corporation - Product segments
  • Exhibit 72: Edwards Lifesciences Corporation - Organizational developments
  • Exhibit 73: Edwards Lifesciences Corporation - Geographic focus
  • Exhibit 74: Edwards Lifesciences Corporation - Segment focus
  • Exhibit 75: Edwards Lifesciences Corporation - Key offerings
  • Exhibit 76: LivaNova PLC - Vendor overview
  • Exhibit 77: LivaNova PLC - Business segments
  • Exhibit 78: LivaNova PLC - Organizational developments
  • Exhibit 79: LivaNova PLC - Geographic focus
  • Exhibit 80: LivaNova PLC - Segment focus
  • Exhibit 81: LivaNova PLC - Key offerings
  • Exhibit 82: Medtronic - Vendor overview
  • Exhibit 83: Medtronic - Business segments
  • Exhibit 84: Medtronic - Organizational developments
  • Exhibit 85: Medtronic - Geographic focus
  • Exhibit 86: Medtronic - Segment focus
  • Exhibit 87: Medtronic - Key offerings
  • Exhibit 88: Validation techniques employed for market sizing
Back to Top